Access I Deliver I Transform

Sowaka Health, based in the United States, is India’s leading Early Access Program (EAP) company. We are uniquely positioned to deliver unlicensed and innovative therapies where no other partner can. From navigating CDSCO and AERB approvals to direct U.S./EU sourcing, GDP-certified cold chain, import clearance, demand generation, and last-mile delivery, we manage the entire EAP journey. With strong expertise in oncology and rare diseases, and an upcoming focus on nuclear medicines, Sowaka Health provides pharma, physicians, and hospitals with a seamless, compliant, and patient-centric access platform for India and beyond.

At Sowaka Health, everything begins with the patient. Our company was founded on personal experience and the belief that access to innovative therapies should never be limited by borders, regulatory delays, or fragmented supply chains. Whether it is a child living with a rare condition, a cancer patient in urgent need, or a family searching for hope when all options seem exhausted, we ensure that life-changing medicines reach those who need them most. By combining global sourcing expertise with India-focused regulatory strength, we simplify complexity and deliver more than just medicines—we deliver dignity, trust, and time to patients and their loved ones.

Life Sciences

Sowaka Health

Org chart

Teams

Offices

Sowaka Health

Org chart

Teams

Offices

Related companies